SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe E. who wrote (5768)12/15/1998 12:34:00 PM
From: sam  Read Replies (2) of 6136
 
Isn't "curing the common cold" one of those ambitions we used to believe were impossible (like bringing peace to the Middle East or eradicating world hunger)? I think it will be worth at least a 1 or 2 point pop on the initial news release. Kidding of course. Particularly since AGPH's stock has performed remarkably well during the last few months. No complaint here. With the stock or the company. FWIW, price (in addition to the drug's profile) may also be a factor in its widespread acceptance.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News